prostate cancer

Open Access
¹⁸F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology
Medhat M. Osman, Amir Iravani, Catherine Mitchell, Rodney J. Hicks, Elisa Perry and Michael S. Hofman

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1383-1386; DOI: https://doi.org/10.2967/jnumed.124.267772
You have access
Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer
John Nikitas, Angela Castellanos Rieger, Andrea Farolfi, Ameen Seyedroudbari, Amar U. Kishan, Nicholas G. Nickols, Michael L. Steinberg, Luca F. Valle, Matthew Rettig, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1387-1394; DOI: https://doi.org/10.2967/jnumed.124.267922
You have access
Neurologic Symptoms After ¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience
Gokce Belge Bilgin, Brian J. Burkett, Cem Bilgin, Jacob J. Orme, Daniel S. Childs, Miguel Muniz Rincon, Ahmad S. Abdelrazek, Derek R. Johnson, Geoffrey B. Johnson, Eugene D. Kwon, Oliver Sartor and Ayse Tuba Kendi

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1402-1408; DOI: https://doi.org/10.2967/jnumed.124.267643
Open Access
⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, Sandra Zanger, Raghuvir H. Gaonkar, Lisa McDougall, Francesco De Rose, Leila Jaafar-Thiel, Michael Herz, Matthias Eiber, Gary A. Ulaner, Wolfgang A. Weber and Melpomeni Fani

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1427-1434; DOI: https://doi.org/10.2967/jnumed.123.267126
Open Access
Single Chelator–Minibody Theranostic Agents for ⁸⁹Zr PET Imaging and ¹⁷⁷Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer
Khanh-Van Ho, David S. Tatum, Lisa Watkinson, Terry Carmack, Fang Jia, Alessandro Mascioni, Charles A. Maitz, Darren Magda and Carolyn J. Anderson

Journal of Nuclear Medicine September 1, 2024, 65 (9) 1435-1442; DOI: https://doi.org/10.2967/jnumed.124.267667
Open Access
Prostate-Specific Membrane Antigen–Targeted Imaging and Its Correlation with HOXB13 Expression
Duminduni Hewa Angappulige, Nimrod S. Barashi, Nicholas Pickersgill, Cody Weimholt, Jingqin Luo, Ghazal Shadmani, Ziad Tarcha, Sampanna Rayamajhi, Nupam P. Mahajan, Gerald L. Andriole, Barry A. Siegel, Eric H. Kim and Kiran Mahajan

Journal of Nuclear Medicine August 1, 2024, 65 (8) 1210-1216; DOI: https://doi.org/10.2967/jnumed.123.267301
You have access
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [¹⁶¹Tb]Tb-PSMA-I&T
James P. Buteau, Louise Kostos, Ramin Alipour, Price Jackson, Lachlan McInstosh, Brittany Emmerson, Mohammad B. Haskali, Jing Xie, Elizabeth Medhurst, Rajeev Ravi, Brian D. Gonzalez, Heidi Fettke, Benjamin Blyth, Luc Furic, Katie Owen, Shahneen Sandhu, Declan G. Murphy, Arun A. Azad and Michael S. Hofman

Journal of Nuclear Medicine August 1, 2024, 65 (8) 1231-1238; DOI: https://doi.org/10.2967/jnumed.124.267650
You have access
Synthesis of ⁶⁴Cu-, ⁵⁵Co-, and ⁶⁸Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles
German O. Fonseca Cabrera, Xinrui Ma, Wilson Lin, Tao Zhang, Weiling Zhao, Liqin Pan, Xiaomei Li, Todd E. Barnhart, Eduardo Aluicio-Sarduy, Huaifu Deng, Xuedan Wu, Kadalipura P. Rakesh, Zibo Li, Jonathan W. Engle and Zhanhong Wu

Journal of Nuclear Medicine August 1, 2024, 65 (8) 1250-1256; DOI: https://doi.org/10.2967/jnumed.124.267469
You have access
Dosimetry of [¹⁷⁷Lu]Lu-PSMA–Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
Zachary Ells, Tristan R. Grogan, Johannes Czernin, Magnus Dahlbom and Jeremie Calais

Journal of Nuclear Medicine August 1, 2024, 65 (8) 1264-1271; DOI: https://doi.org/10.2967/jnumed.124.267452
You have access
A Prospective Randomized Multicenter Study on the Impact of [¹⁸F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer
Laura Evangelista, Fabio Zattoni, Marta Burei, Daniele Bertin, Eugenio Borsatti, Tanja Baresic, Mohsen Farsad, Emanuela Trenti, Mirco Bartolomei, Stefano Panareo, Luca Urso, Giuseppe Trifirò, Elisabetta Brugola, Franca Chierichetti, Davide Donner, Lucia Setti, Mauro Gallan, Paola Del Bianco, Giovanna Magni, Gian Luca De Salvo, Giacomo Novara and the Study Group Coinvestigators

Journal of Nuclear Medicine July 1, 2024, 65 (7) 1013-1020; DOI: https://doi.org/10.2967/jnumed.123.267355

Main menu

User menu

Search

prostate cancer

Pages